Redwood City, United States
Integrated Biosciences, Inc., founded in 2022 and headquartered in the United States, is at the forefront of accelerating drug discovery through its innovative approach to biopharma and biotechnology. The company's slogan, "Unravelling complex biology with optogenetics, chemistry and computation for small molecule discovery," encapsulates its mission and technological edge.
With a proprietary synthetic biology toolkit, Integrated Biosciences leverages advanced optogenetic tools for precise control over complex pathways, targeting difficult-to-drug targets. Their platform, powered by vast proprietary datasets and cutting-edge AI models, facilitates the creation of novel chemical entities, addressing challenging biological systems in the life sciences sector.
In its Seed Round, the company attracted prominent investors such as Conscience, Reinforced Ventures, Mission BioCapital, Root Ventures, and Polymath Capital in September 2022. Integrated Biosciences represents a promising investment opportunity, merging synthetic biology with machine learning to transform drug discovery processes.
